Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor

Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor

Bibliographic Details
Main Authors:	Sugihara, Takuro, Takahashi, Isao, Kojima, Tetsuhito, Okamoto, Yoshihiro, Yamamoto, Koji, Kamiya, Tadashi, Matsushita, Tadashi, Saito, Hidehiko
Language:	en_US
Published:	Nagoya University School of Medicine 2000
Subjects:	Factor VIII Hemophilia A Factor VIII inhibitor Southern blotting Gene inversion
Online Access:	http://hdl.handle.net/2237/5351

Similar Items

Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?
by: Lieuw K
Published: (2017-06-01)

Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors
by: Shuichi Okamoto, et al.
Published: (2019-10-01)

Clinical and Laboratory Approaches to Hemophilia A
by: Hassan Mansouritorghabeh
Published: (2015-05-01)

Potential role of a new PEGylated recombinant factor VIII for hemophilia A
by: Wynn TT, et al.
Published: (2016-06-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study
by: Zhen-Ping Chen, et al.
Published: (2018-01-01)

Desenvolvimento de inibidores do fator VIII na hemofilia A Development of factor VIII inhibitors in hemophilia A
by: Daniel G. Chaves, et al.
Published: (2009-01-01)

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
by: Byung Suk Moon, et al.
Published: (2013-07-01)

The prevalence of factor VIII inhibitor in patients with severe hemophilia-A and its clinical characteristics
by: Harijadi Harijadi, et al.
Published: (2016-10-01)

Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents
by: Shannon Jackson, et al.
Published: (2019-04-01)

A case of subdural hematoma with a medical history of hemophilia a and a review of related literature
by: Yi Zhao, et al.
Published: (2018-05-01)

A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in north eastern part of India
by: Sandip Kumar, et al.
Published: (2019-01-01)

“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India
by: Sangita Darshan Shah, et al.
Published: (2019-01-01)

Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
by: Beth Boulden Warren, et al.
Published: (2021-07-01)

A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy
by: Alex C. Chen, et al.
Published: (2020-04-01)

Perioperative management of patient with hemophilia a underwent orthopedic surgery
by: Tjokorda G A Senapathi, et al.
Published: (2017-01-01)

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy
by: Daniela Paola Roggeri, et al.
Published: (2017-10-01)

Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII
by: Jenni Firrman, et al.
Published: (2020-06-01)

Anesthetic management of a patient with hemophilia A with spontaneous acute subdural hematoma
by: Prakhar Gyanesh, et al.
Published: (2013-01-01)

Tolerance Induction and The Immunobiology of Factor VIII in Hemophilia A
by: WATERS, BRADEN
Published: (2010)

[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]
by: Lucia Sara D'Angiolella, et al.
Published: (2017-02-01)

Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion
by: Jeong Pil Han, et al.
Published: (2021-07-01)

Perioperative Management of Patients with Hemophilia during Spinal Surgery
by: Kazuyoshi Kobayashi, et al.
Published: (2018-06-01)

Development of inhibitors in hemophilia A: An illustrated review
by: Letícia Lemos Jardim, et al.
Published: (2020-07-01)

[Kovaltry® for the replacement therapy in patients with Hemophilia A]
by: Daniela Paola Roggeri, et al.
Published: (2016-06-01)

CLINICAL EFFICACY OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN IN HAEMOPHILIA A PATIENT RECEIVING ON DEMAND TREATMENT ONLY
by: Saima Zahir, et al.
Published: (2021-02-01)

Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A
by: Pratima Chowdary, et al.
Published: (2019-07-01)

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A
by: Di Minno G, et al.
Published: (2019-01-01)

Giant Intramural Hematoma of the Colon in Acquired Factor VIII Inhibitor
by: Joana Figueiredo, et al.
Published: (2019-09-01)

The Effect of 8-Weeks Exercise in Water on Factor VIII and Partial Thromboplastin Time (PTT) of Men with Hemophilia
by: Marziyeh Soltani, et al.
Published: (2016-01-01)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
by: Jerome Teitel, et al.
Published: (2021-02-01)

Systematic molecular analysis of hemophilia A patients from Colombia
by: Luz Karime Yunis, et al.
Published: (2018-11-01)

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients
by: Hassan Abolghasemi, MD, et al.
Published: (2018-06-01)

Post Splenectomy Fatal Pulmonary Embolism in a Patient with Moderate Hemophilia A
by: Abdolhossein Davoodabadi, et al.
Published: (2011-06-01)

Hemophilia in the newborn without family history: Pattern of clinical presentation of three patients
by: Kuzmanović Miloš, et al.
Published: (2010-01-01)

Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
by: Laila M. Sherief, et al.
Published: (2020-09-01)

Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors
by: Anshu Shrestha, et al.
Published: (2021-01-01)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
by: Jacky K. Yu, et al.
Published: (2019-07-01)

Acquired Hemophilia A with Gastrointestinal Bleeding
by: Narae Park, et al.
Published: (2020-01-01)

Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations
by: Farzaneh Nasirnejad Sola, et al.
Published: (2020-12-01)